The global gynecology devices market was valued at USD 11.09 billion in 2024, the base year of the study. Polaris Market Research estimates the market at USD 12.05 billion in 2025 and projects it to reach USD 25.81 billion by 2034, growing at a CAGR of 8.8% during the forecast period 2025–2034. Growth is supported by a rising population, improved healthcare access in emerging regions, technological advancements, and greater adoption of minimally invasive procedures. Key players include Bayer AG, Boston Scientific Corp., Cook Medical, Cooper Surgical, Inc., Ethicon, Inc. (Johnson & Johnson MedTech), Gynemed, Gynex Corp, Hologic, Inc., Karl Storz GmbH & Co. KG, Medtronic plc, Richard Wolf GmbH, and Stryker Corp.

Surgical Devices Lead Product Demand

Surgical devices dominated the gynecology devices market in 2024 because of the rising prevalence of conditions such as uterine fibroids, endometriosis, and ovarian cysts that require surgical intervention. Minimally invasive procedures, including laparoscopy and robotic-assisted surgeries, have gained popularity for faster recovery times and reduced complications. Technological advancements in electrosurgical devices, morcellators, and endoscopy systems have improved precision and patient outcomes, while more gynecologists are being trained in these techniques and patients show a preference for less invasive options.

Hysteroscopes and Robotics Raise Clinical Precision

High-definition hysteroscopes and laparoscopes allow better visualization during surgery, while robotic-assisted systems enable surgeons to perform complex operations with greater control. Recent launches reflect this direction. In May 2025, Minerva Surgical launched the HERizon Hysto-Kit, a single-use, pre-assembled hysteroscopy kit designed to streamline office-based procedures. In February 2025, Aspivix launched Carevix, a cervical device designed to reduce pain and bleeding during transcervical procedures. In April 2024, Moon Surgical and the Franche-Comté Polyclinic introduced the Maestro System for gynecological laparoscopic procedures in France, enabling eight surgeons to complete hysterectomy, cystectomy, adnexectomy, and ovariectomy cases after a one-hour training.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/gynecology-devices-market

Ambulatory Surgery Centers Expand Outpatient Capacity

The ambulatory surgery centers segment is expected to experience significant growth during the forecast period. These facilities offer a convenient, cost-effective setting for minor and minimally invasive procedures, supported by advances in surgical equipment and anesthesia that allow quicker recovery and same-day discharge. Shorter wait times and lower overhead costs compared with hospitals have led to more gynecological procedures being performed in these settings. Hospitals and clinics nonetheless dominated end-user share in 2024, given their advanced diagnostic and surgical infrastructure and skilled multidisciplinary teams.

Technology Adoption and Growth Drivers

Beyond procedure mix, the market is supported by a rising population, improved healthcare access in emerging regions, and increasing gynecological disorders. Emerging economies in Asia, Latin America, and Africa are investing in hospitals, clinics, and diagnostic centers. As manufacturers invest in research and development, healthcare facilities are more willing to adopt advanced devices that support high-quality care, and the integration of new technologies is encouraging wider use and replacement of traditional gynecological instruments.

Gynecology Devices Market Regional Outlook

North America dominated the market in 2024, driven by advanced healthcare infrastructure, high healthcare spending, and early adoption of innovative technologies, along with a high incidence of uterine fibroids and endometriosis. In the US, a growing preference for outpatient care is boosting demand for portable and minimally invasive devices, and FDA oversight supports quality and innovation. Asia Pacific is projected to witness substantial growth on a rising population, increasing awareness, and improving healthcare infrastructure, while Germany's robust healthcare infrastructure supports adoption of laparoscopic instruments and advanced imaging systems. High initial investment remains a restraint for the industry.

Competitive Landscape

Medtronic plc, Boston Scientific Corp., and Stryker Corp. have diversified portfolios and strong R&D capabilities across gynecology devices diagnostics, surgical tools, and minimally invasive systems, while Karl Storz GmbH & Co. KG and Richard Wolf GmbH specialize in endoscope and visualization systems. Continuous product innovation, regulatory approvals, and geographic expansion remain key strategies shaping competition.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market